Preliminary results of the Australasian Regional Anaesthesia Collaboration: a prospective audit of more than 7000 peripheral nerve and plexus blocks for neurologic and other complications.
OBJECTIVE
Peripheral nerve blockade is associated with excellent patient outcomes after surgery; however, neurologic and other complications can be devastating for the patient. This article reports the development and preliminary results of a multicenter audit describing the quality and safety of peripheral nerve blockade.


METHODS
From January 2006 to May 2008, patients who received peripheral nerve blockade had data relating to efficacy and complications entered into databases. All patients who received nerve blocks performed by all anesthetists during each hospital's contributing period were included. Patients were followed up by phone to detect potential neurologic complications. The timing of follow-up was either at 7 to 10 days or 6 weeks postoperatively, depending on practice location and time period. Late neurologic deficits were defined as a new onset of sensory and/or motor deficit consistent with a nerve/plexus distribution without other identifiable cause, and one of the following: electrophysiologic evidence of nerve damage, new neurologic signs, new onset of neuropathic pain in a nerve distribution area, paresthesia in relevant nerve/plexus distribution area.


RESULTS
A total of 6950 patients received 8189 peripheral nerve or plexus blocks. Of the 6950 patients, 6069 patients were successfully followed up. In these 6069 patients, there were a total of 7156 blocks forming the denominator for late neurologic complications. Thirty patients (0.5%) had clinical features requiring referral for neurologic assessment. Three of the 30 patients had a block-related nerve injury, giving an incidence of 0.4 per 1000 blocks (95% confidence interval, 0.08-1.1:1000). The incidence of systemic local anesthetic toxicity was 0.98 per 1000 blocks (95% confidence interval, 0.42-1.9:1000).


CONCLUSIONS
These results indicate that the incidence of serious complications after peripheral nerve blockade is uncommon and that the origin of neurologic symptoms/signs in the postoperative period is most likely to be unrelated to nerve blockade.
Barrington
Michael J
MJ
Department of Anaesthesia, St Vincent's Hospital, Melbourne, Victoria, Australia. Barrington@svhm.org.au
Watts
Steve A
SA
Gledhill
Samuel R
SR
Thomas
Rowan D
RD
Said
Simone A
SA
Snyder
Gabriel L
GL
Tay
Valerie S
VS
Jamrozik
Konrad
K
D000577:Amides / Q000008:administration & dosage / Q000506:poisoning; D000779:Anesthetics, Local / Q000008:administration & dosage / Q000506:poisoning; D044362:Australasia / Q000453:epidemiology; D002045:Bupivacaine / Q000008:administration & dosage / Q000506:poisoning; D002985:Clinical Protocols; D006801:Humans; D008012:Lidocaine / Q000008:administration & dosage / Q000506:poisoning; D008485:Medical Audit; D009407:Nerve Block / Q000009:adverse effects* / Q000592:standards; D009422:Nervous System Diseases / Q000453:epidemiology / Q000209:etiology; D010525:Peripheral Nerves; D011446:Prospective Studies; D000077212:Ropivacaine; D012449:Safety; D004561:Transcutaneous Electric Nerve Stimulation; D016896:Treatment Outcome; D018084:Ultrasonography, Interventional
D000577:Amides; D000779:Anesthetics, Local; D000077212:Ropivacaine; D008012:Lidocaine; D002045:Bupivacaine